Capstone Investment Advisors LLC Acquires 17,070 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC)

Capstone Investment Advisors LLC raised its holdings in Alphatec Holdings, Inc. (NASDAQ:ATEC) by 113.8% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,070 shares of the medical technology company’s stock after buying an additional 17,070 shares during the period. Capstone Investment Advisors LLC’s holdings in Alphatec were worth $178,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. raised its position in shares of Alphatec by 1.2% in the first quarter. Vanguard Group Inc. now owns 5,458,847 shares of the medical technology company’s stock valued at $75,278,000 after purchasing an additional 64,648 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in Alphatec by 14.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,346 shares of the medical technology company’s stock valued at $364,000 after acquiring an additional 3,268 shares during the period. Comerica Bank lifted its position in Alphatec by 64.8% during the first quarter. Comerica Bank now owns 6,443 shares of the medical technology company’s stock worth $89,000 after acquiring an additional 2,534 shares during the last quarter. Cetera Advisors LLC boosted its holdings in shares of Alphatec by 15.6% during the first quarter. Cetera Advisors LLC now owns 12,720 shares of the medical technology company’s stock worth $175,000 after acquiring an additional 1,720 shares during the period. Finally, SG Americas Securities LLC grew its position in shares of Alphatec by 44.6% in the second quarter. SG Americas Securities LLC now owns 14,495 shares of the medical technology company’s stock valued at $151,000 after purchasing an additional 4,472 shares during the last quarter. 66.35% of the stock is owned by institutional investors and hedge funds.

Alphatec Stock Performance

NASDAQ ATEC opened at $10.48 on Monday. The firm’s 50 day simple moving average is $7.11 and its 200 day simple moving average is $8.18. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of -8.19 and a beta of 1.31. The company has a current ratio of 2.32, a quick ratio of 1.15 and a debt-to-equity ratio of 30.21. Alphatec Holdings, Inc. has a 1 year low of $4.88 and a 1 year high of $17.34.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. HC Wainwright reissued a “buy” rating and set a $20.00 price target on shares of Alphatec in a report on Thursday, October 31st. Needham & Company LLC reissued a “buy” rating and issued a $13.00 target price on shares of Alphatec in a research report on Thursday, October 31st. Lake Street Capital dropped their price objective on shares of Alphatec from $32.00 to $18.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd. Canaccord Genuity Group reissued a “buy” rating and issued a $20.00 price objective on shares of Alphatec in a report on Friday, August 30th. Finally, Barclays raised their target price on shares of Alphatec from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $17.11.

Alphatec Profile

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.